Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026)
Absci's (ABSI) quarterly Change in Acquisitions & Divestments came in at $26.0 million in Q1 2026, up 4.0% year-on-year from $25.0 million in Q1 2025, and up 503.25% quarter-over-quarter from $4.3 million in Q4 2025.
Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Absci has disclosed Change in Acquisitions & Divestments across 5 years of filings, most recently posting $26.0 million for Q1 2026.
- Change in Acquisitions & Divestments for Q1 2026 came in at $26.0 million, up 4.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $70.5 million (down 52.52% YoY), and the FY2025 annual result was $69.5 million, down 51.74% from the prior year.
- Change in Acquisitions & Divestments came in at $26.0 million for Q1 2026 at Absci, up from $4.3 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $93.9 million in Q2 2023 to a low of $4.3 million in Q4 2025.
- The 5-year median for Change in Acquisitions & Divestments is $30.8 million (2024), against an average of $33.9 million.
- Across the five-year window, Change in Acquisitions & Divestments soared 780.0% in 2023 and sank 90.42% in 2025, its largest moves.
- Absci's Change in Acquisitions & Divestments stood at $5.0 million in 2022, then surged by 780.0% to $44.0 million in 2023, then gained by 2.27% to $45.0 million in 2024, then tumbled by 90.42% to $4.3 million in 2025, then surged by 503.25% to $26.0 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $26.0 million (Q1 2026), $4.3 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.00 Mn |
| Mar 31, 2026 | 26.00 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 14.19 Mn |
| Sep 30, 2025 | 14.19 Mn |
| Jun 30, 2025 | 26.00 Mn |
| Jun 30, 2025 | 26.00 Mn |
| Mar 31, 2025 | 25.00 Mn |
| Mar 31, 2025 | 25.00 Mn |
| Dec 31, 2024 | 45.00 Mn |
| Dec 31, 2024 | 45.00 Mn |
| Sep 30, 2024 | 43.00 Mn |
| Sep 30, 2024 | 43.00 Mn |
| Jun 30, 2024 | 35.50 Mn |
| Jun 30, 2024 | 35.50 Mn |
| Mar 31, 2024 | 20.50 Mn |
| Mar 31, 2024 | 20.50 Mn |
| Dec 31, 2023 | 44.00 Mn |
| Dec 31, 2023 | 44.00 Mn |